ribavirin has been researched along with Hemophilia A in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (4.69) | 18.2507 |
2000's | 38 (59.38) | 29.6817 |
2010's | 23 (35.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, HJ; Lee, HW; Won, JW; Yoo, KY | 1 |
Chen, J; Li, J; Lu, H; Wang, J; Xiao, H; Yang, F | 1 |
Antón Ródenas, G; Martínez Pascual, C; Ortiz Sánchez, ML; Pons Miñano, JA | 1 |
Barbato, A; Cimino, E; Coppola, A; Di Minno, MN; Granata, F; Liccardo, S; Rossi, D; Ruosi, C | 1 |
Bukatman, R; Gordon, P; Kramer, D; Krug, P; Mermelstein, P | 1 |
Jiangrong, W; Jing, L; Yingying, L | 1 |
Chen, PJ; Chen, YC; Cheng, SN; Chu, HC; Hsieh, TY; Lin, JA; Shih, YL | 1 |
Guner, R; Tufan, ZK | 1 |
Furusyo, N; Hayashi, J; Hiramine, S; Ikezaki, H; Kainuma, M; Mitsumoto, F; Murata, M; Ogawa, E; Shimizu, M; Takayama, K; Toyoda, K | 1 |
Alavian, SM; Keshvari, M; Sharafi, H | 1 |
Lin, JA; Shih, YL | 1 |
Denk, G; Eberle, J; Guba, M; Kaspar, M; Kolligs, F; Pichler, M; Seybold, U; Spannagl, M; Stemberger, M | 1 |
Joshita, S; Tanaka, E | 1 |
Alavian, SM; Behnava, B; Keshvari, M; Mehrnoush, L; Salimi, S; Sharafi, H | 1 |
Lee, BS; Rou, WS | 1 |
Kim, HJ; Lee, HW; Lee, YJ; Park, SJ; Yang, SY; Yoo, KY | 1 |
Bogomolov, P; Cooney, E; Critelli, L; Olveira, A; Pol, S; Reesink, HW; Santagostino, E; Srinivasan, S; van Erpecum, K; Xu, D | 1 |
Alavian, SM; Behnava, B; Craig, JC; Keshvari, M; Pouryasin, A; Sharafi, H | 1 |
Goto, H; Hayashi, K; Honda, T; Ishigami, M; Katano, Y; Nakano, I; Takamatsu, J; Toyoda, H; Yamamoto, K | 1 |
Mangini, C; Pereira, GH | 1 |
Denholm, JT; Sasadeusz, JJ; Street, A; Wright, EJ | 1 |
Aghemo, A; Colombo, M; Coppola, A; Mancuso, ME; Mannucci, PM; Puoti, M; Rumi, MG; Santagostino, E | 1 |
Alavian, SM; Behnava, B; Elizee, PK; Keshvari, M; Lankarani, KB; Miri, SM; Tabatabaei, SV | 1 |
Barcelo de Brito, S; Campos-de-Magalhães, M; Cecília da Fonseca Salgado, M; Eduardo Brandão-Mello, C; José de Almeida, A; Lúcia Elias Pires, M | 1 |
Benicky, M; Benova, B; Gombosova, L; Jarcuska, P; Lazurova, I | 1 |
Băţagă, S; Boţianu, AM; Demian, S; Georgescu, D; Macarie, I; Oltean, G | 1 |
Bailly, F; Zoulim, F | 1 |
Bourlière, M; Halfon, P; Portal, I | 1 |
Abshire, TC; Davis, PC; Fried, MW; Gaglio, PJ; Hoots, K; Key, NS; Lindblad, L; Peter, J; Rickles, FR; Talbut, D; White, GC | 1 |
Misery, L | 1 |
Aprili, G; Capra, F; de Maria, E; Franchini, M; Gandini, G; Pattacini, C; Rossetti, G; Tagliaferri, A; Veneri, D | 1 |
Bica, I; McGovern, B | 1 |
Haagsma, EB; Meijer, K; van der Meer, J | 1 |
Wilde, JT | 1 |
Bouhasin, J; Kane, R; Puetz, J; Thrower, M | 1 |
Chalupa, P; Husa, P; Husová, L; Penka, M; Smejkal, P | 1 |
Colombo, M; De Filippi, F; Mannucci, PM; Rivi, M; Rumi, MG; Santagostino, E | 1 |
Husa, P; Husová, L; Penka, M; Smejkal, P | 1 |
Franchini, M | 2 |
Goto, H; Hayashi, K; Honda, T; Katano, Y; Nakano, I; Takamatsu, J; Toyoda, H; Yamamoto, K; Yano, M; Yoshioka, K | 1 |
Au, WY; Lam, CC; Liu, CL; Yuen, MF | 1 |
Honda, T; Kojima, T; Matsushita, T; Takamatsu, J; Yamamoto, K | 1 |
Kessler, CM | 1 |
Ibrányi, E; Nemes, L | 1 |
Bagheri, H; Barange, K; Bonnet, E; Claeyssens, S; Guitton, E; Massip, P; Montastruc, JL; Vinel, JP | 1 |
Capra, F; Franchini, M; Nicolini, N | 1 |
Fischer, K; Makris, M; Mauser-Bunschoten, EP; Posthouwer, D | 1 |
Bhagani, S; Johnson, M; Killingley, B; Slapak, G; Yee, TT | 1 |
Colombo, M; Coppola, A; Linari, S; Mancuso, ME; Mannucci, PM; Rumi, MG; Santagostino, E | 1 |
Eyster, ME; Horn, PS; Rouster, SD; Sherman, KE; Shire, NJ; Stanford, S | 1 |
Amarapurkar, D; Bowden, S; Chow, WC; Chutaputti, A; Dore, G; Gane, E; Guan, R; Hamid, SS; Hardikar, W; Hui, CK; Jafri, W; Jia, JD; Lai, MY; Leung, N; McCaughan, GW; Omata, M; Piratvisuth, T; Sarin, S; Sollano, J; Tateishi, R; Wei, L | 1 |
Bergin, C; Farrell, G; Hopkins, S; Kevans, D; Mahmud, N; Norris, S; White, B | 1 |
Avidan, B; Bar-Meir, S; Bashari, D; Lurie, Y; Maor, Y; Martinowitz, U; Paritsky, M; Rachlis, Z; Safadi, R; Schapiro, JM; Segol, O | 1 |
Cruciani, M; Franchini, M; Lippi, G; Mazzi, R; Mengoli, C; Veneri, D | 1 |
Ebeling, F | 1 |
Bellini, WJ; Mustafa, MM; Siegel, JD; Timmons, CF; Weitman, SD; Winick, NJ | 1 |
Angel, JB; DeLellis, RA; Lerch, RA; Masurekar, M; Noble, JT; Sidhu, MS; Snydman, DR; Udem, SA; Walpita, P | 1 |
Altisent, C; Esteban, JI; Esteban, R; Guardia, J; Puig, L; Sauleda, S | 1 |
Aguilar, C; Lucia, JF; Simón, MA | 1 |
Berntorp, E; Lethagen, S; Lindgren, S; Verbaan, H; Widell, A | 1 |
Capra, F; De Maria, E; Franchini, M; Gandini, G | 1 |
Colombo, M; Mannucci, PM; Rivi, M; Rumi, MG; Santagostino, E | 1 |
Fukuda, Y; Hayashi, K; Nakano, I; Takamatsu, J; Toyoda, H | 1 |
11 review(s) available for ribavirin and Hemophilia A
Article | Year |
---|---|
[Treatment of chronic hepatitis C in special groups].
Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Follow-Up Studies; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Renal Dialysis; Ribavirin; Thalassemia; Time Factors | 2002 |
HIV and HCV coinfection in haemophilia.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Interactions; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferons; Liver Transplantation; Ribavirin; Transaminases; Viremia | 2004 |
Hepatitis C in haemophiliacs.
Topics: Female; Genotype; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferons; Male; Ribavirin; Time Factors; Treatment Outcome | 2004 |
Update on liver disease in hemophilia patients.
Topics: Antiviral Agents; Factor VII; Factor VIIa; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Recombinant Proteins; Ribavirin | 2006 |
Treatment of hepatitis C in hemophiliacs.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferon Type I; Liver Transplantation; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.
Topics: Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; HIV Seronegativity; HIV Seropositivity; Humans; Interferons; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Case Management; Clinical Trials as Topic; Cohort Studies; Disease Progression; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Multicenter Studies as Topic; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2006 |
Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis.
Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Treatment Outcome; Viremia | 2008 |
Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature.
Topics: Adult; Base Sequence; Child, Preschool; Encephalitis; Female; Hemophilia A; HIV Infections; Humans; Immunocompromised Host; Male; Measles; Measles virus; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin; Time Factors | 1993 |
An emerging role for interferon in haemophiliacs with chronic hepatitis C?
Topics: Antiviral Agents; Chronic Disease; Hemophilia A; Hepatitis C; Humans; Interferons; Ribavirin | 2001 |
[Impact of HIV on HCV, GBV-C/HGV, and HBV infection].
Topics: Anti-HIV Agents; Antibiosis; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Flaviviridae Infections; GB virus C; Hemophilia A; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; HIV-1; Humans; Interferons; Lamivudine; Liver Neoplasms; Liver Transplantation; Prognosis; Ribavirin | 2002 |
12 trial(s) available for ribavirin and Hemophilia A
Article | Year |
---|---|
High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study.
Topics: Adolescent; Adult; Case-Control Studies; Child; Drug Therapy, Combination; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2015 |
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Recurrence; Republic of Korea; Ribavirin; RNA, Viral; Treatment Outcome | 2015 |
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
Topics: Adult; Antiviral Agents; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferon-alpha; Interferons; Interleukins; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Valine; Young Adult | 2016 |
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
Topics: Adult; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferons; Liver Diseases; Male; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2009 |
Peginterferon alpha-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases.
Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hemophilia A; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Iran; Odds Ratio; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral | 2010 |
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2002 |
Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Failure | 2002 |
A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia.
Topics: Adolescent; Adult; Antiviral Agents; Blood Coagulation Disorders; Double-Blind Method; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin | 2004 |
Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Ribavirin | 2004 |
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.
Topics: Adult; Drug Therapy, Combination; Female; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2006 |
HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Antiviral Agents; CD4-Positive T-Lymphocytes; Female; Follow-Up Studies; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Remission Induction; Ribavirin; RNA, Viral; Viral Load | 2006 |
Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Hemophilia A; Hepacivirus; Hepatitis C; Humans; Interferons; Male; Middle Aged; Ribavirin; Treatment Outcome | 2002 |
41 other study(ies) available for ribavirin and Hemophilia A
Article | Year |
---|---|
Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Drug Resistance, Viral; Female; Fluorenes; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Male; Middle Aged; Pyrrolidines; Republic of Korea; Retrospective Studies; Ribavirin; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Uridine Monophosphate; Valine | 2017 |
Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Topics: Adult; Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Imidazoles; Interferons; Isoquinolines; Male; Middle Aged; Pyrrolidines; Retrospective Studies; Ribavirin; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine | 2019 |
[Acquired hemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with peginterferon α-2a].
Topics: Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Autoantibodies; Autoantigens; Cyclophosphamide; Factor VIII; Glucocorticoids; Hematoma; Hemophilia A; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab | 2013 |
Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report.
Topics: Antiviral Agents; Arthropathy, Neurogenic; Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Hemophilia A; Hepatitis C; Hip; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Middle Aged; Polyethylene Glycols; Radiography; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2013 |
Energy dialogue technique in healing and health: relieving side effects and thyroid dysfunction in a male with hemophilia receiving pegylated interferon and ribavirin treatment for hepatitis C virus--an anecdotal case study.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mind-Body Relations, Metaphysical; Ribavirin; Thyroid Diseases; Thyroid Gland | 2013 |
Characteristics of the cellular immune response in HIV/HCV patients with hemophilia during peginterferon/ribavirin therapy in southern China.
Topics: Adult; Antiviral Agents; China; Cytokines; Enzyme-Linked Immunospot Assay; Female; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Immunity, Cellular; Interferons; Interleukins; Leukocytes, Mononuclear; Male; Polymorphism, Single Nucleotide; Ribavirin; Young Adult | 2014 |
Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Taiwan; Treatment Outcome; Viral Load | 2014 |
Telaprevir use in a chronic hepatitis C patient with hemophilia.
Topics: Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Ribavirin; Treatment Outcome | 2014 |
A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2014 |
Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment.
Topics: Antiviral Agents; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2015 |
Reply to "Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment".
Topics: Antiviral Agents; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2015 |
Haemophilia-related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV-HIV coinfected man with liver failure and hepatocellular carcinoma.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Hemophilia A; Hepatitis C; HIV Infections; Humans; Liver Failure; Liver Transplantation; Male; Ribavirin; Sofosbuvir; Treatment Outcome; Uridine Monophosphate | 2015 |
[Natural human IFNβ and ribavirin combination therapy].
Topics: Aged; Depression; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-beta; Ribavirin; Thrombocytopenia | 2015 |
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
Topics: Antiviral Agents; Female; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2015 |
Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Female; Genetic Association Studies; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Sustained Virologic Response; Young Adult | 2017 |
Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors.
Topics: Antiviral Agents; Drug Therapy, Combination; Factor VII; Hemophilia A; Hemorrhage; Hepatitis C, Chronic; Humans; Interferon-alpha; Mental Disorders; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2008 |
Treatment of chronic hepatitis C virus infection among Brazilian haemophiliacs.
Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome; Young Adult | 2008 |
HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Australia; Genotype; Hemophilia A; Hepacivirus; HIV-1; Humans; Interferons; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome | 2009 |
Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin.
Topics: Antiviral Agents; Autoantibodies; Drug Therapy, Combination; Factor IX; Factor VIII; Hemophilia A; Hemophilia B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.
Topics: Adult; Celiac Disease; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Acquired haemophilia complicated with gastrointestinal bleeding and spontaneous iliopsoas muscle haematoma in a woman with chronic C hepatitis under treatment with pegylated IFN alpha 2a and ribavirin.
Topics: Antiviral Agents; Female; Gastrointestinal Hemorrhage; Hematoma; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Psoas Muscles; Recombinant Proteins; Ribavirin | 2012 |
New approaches to the management of hepatitis C in haemophilia in 2012.
Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2012 |
Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hair Removal; Hemophilia A; Hepatitis C; Humans; Hypertrichosis; Interferon-alpha; Male; Ribavirin | 2002 |
Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hemophilia A; Hepatitis C; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Interferons; Ribavirin | 2003 |
Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center.
Topics: Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hemophilia B; Humans; Infant; Interferon-alpha; Male; Ribavirin; Treatment Outcome; Viral Load | 2004 |
[Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
Topics: Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon Type I; Recombinant Proteins; Ribavirin | 2004 |
Treatment of chronic hepatitis C in hemophilic patients.
Topics: Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon Type I; Recombinant Proteins; Ribavirin | 2004 |
Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.
Topics: Adult; Antiviral Agents; Blood Coagulation Factors; Hemophilia A; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Ribavirin | 2005 |
Hepatitis C virus infection in adult Chinese hemophilia patients negative for the human immunodeficiency virus: treatment results with interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; China; Female; Hemophilia A; Hepatitis C; HIV; HIV Seropositivity; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome | 2005 |
Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin.
Topics: Adult; Antiviral Agents; Cells, Cultured; Factor VII; Gene Expression; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Male; Middle Aged; Ribavirin; RNA, Messenger | 2006 |
[Treatment of chronic hepatitis C in haemophilia patients].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
Blood transaminase elevation with pegylated interferon alfa 2b plus ribavirin in an HIV/HCV coinfected haemophilic patient.
Topics: Adult; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Transaminases; Treatment Outcome | 2006 |
Tuberculosis complicating treatment of hepatitis C in an HIV-infected haemophilia A patient.
Topics: Adult; Antiviral Agents; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Lymphadenitis; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Tuberculosis, Lymph Node | 2006 |
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Asia; Australia; Child; Communicable Disease Control; Genotype; Hemophilia A; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Immunoenzyme Techniques; Interferon-alpha; Kidney Failure, Chronic; Liver Transplantation; Molecular Diagnostic Techniques; Reagent Kits, Diagnostic; Ribavirin; RNA, Viral; Thalassemia; Treatment Outcome; Viral Load | 2007 |
Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes.
Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Genotype; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Viral Load | 2007 |
Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience.
Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hemorrhage; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Israel; Liver; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2008 |
[Hepatitis C in Scandinavia].
Topics: Carrier State; Hemophilia A; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Risk Factors; Scandinavian and Nordic Countries; Substance Abuse, Intravenous | 1995 |
Vaccine-associated measles pneumonitis in an adult with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Hemophilia A; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Measles Vaccine; Pneumonia; Ribavirin; Vaccines, Attenuated | 1998 |
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Alanine Transaminase; Antiviral Agents; Blood Coagulation Disorders; Child; Chronic Disease; Drug Therapy, Combination; Factor VII Deficiency; Female; Hemoglobins; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C; HIV Antibodies; HIV Seronegativity; Humans; Interferons; Male; Middle Aged; Neutrophils; Platelet Count; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; von Willebrand Diseases | 2000 |
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Genotype; Hemophilia A; Hepatitis C; Humans; Interferon-alpha; Liver; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome; Ultrasonography; von Willebrand Diseases | 2001 |
Effective antiviral treatment for hepatitis C virus-related chronic active hepatitis in haemophiliac patients.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin | 2001 |